Roni Adiri

Herzliya Pituah, TA, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Clinical Characteristics and Treatment Patterns in Patients With Vitiligo.

Clinical Characteristics and Treatment Patterns in Patients With Vitiligo.

Journal: JAMA dermatology

Published: May 06, 2026

Treatment priorities and unmet needs according to adults and adolescents with nonsegmental vitiligo in the United States.

Treatment priorities and unmet needs according to adults and adolescents with nonsegmental vitiligo in the United States.

Journal: The Journal of dermatological treatment

Published: March 23, 2026

Healthcare Providers' Perspectives on Nonsegmental Vitiligo Severity, Patient Impact, and Treatment Gaps in the United States and Europe.

Healthcare Providers' Perspectives on Nonsegmental Vitiligo Severity, Patient Impact, and Treatment Gaps in the United States and Europe.

Journal: The British journal of dermatology

Published: February 25, 2026

Automated Measurement of Depigmentation Extent with a New AI Tool Applied to the Example of Vitiligo.

Automated Measurement of Depigmentation Extent with a New AI Tool Applied to the Example of Vitiligo.

Journal: Dermatology and therapy

Published: January 09, 2026

Validation of Self-Reported Vitiligo Prevalence among Adults in the USA and Europe Using the 2024 National Health and Wellness Survey.

Validation of Self-Reported Vitiligo Prevalence among Adults in the USA and Europe Using the 2024 National Health and Wellness Survey.

Journal: Dermatology and therapy

Published: December 23, 2025

Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo.

Description of the Tranquillo Phase 3 Clinical Trial Designs/Study Protocols to Assess Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo.

Journal: Dermatology and therapy

Published: December 15, 2025

Risk of Safety Events in Vitiligo Patients: A Retrospective Real-World Data Study in the US.

Risk of Safety Events in Vitiligo Patients: A Retrospective Real-World Data Study in the US.

Journal: The Journal of dermatology

Published: November 10, 2025

The role of JAK3 and TEC family kinases in vitiligo pathogenesis.

The role of JAK3 and TEC family kinases in vitiligo pathogenesis.

Journal: Frontiers in immunology

Published: July 08, 2025

Demographics and Clinical Characteristics among Patients with Distinct Psychosocial Burden Profiles Related to Vitiligo: Results of a Latent Class Analysis.

Demographics and Clinical Characteristics among Patients with Distinct Psychosocial Burden Profiles Related to Vitiligo: Results of a Latent Class Analysis.

Journal: Dermatology and therapy

Published: January 31, 2025

Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension study.

Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension study.

Journal: Journal of the American Academy of Dermatology

Published: June 28, 2024

Phosphodiesterase-4 Inhibitors Increase Pigment Cell Proliferation and Melanization in Cultured Melanocytes and within a 3-Dimensional Skin Equivalent Model.

Phosphodiesterase-4 Inhibitors Increase Pigment Cell Proliferation and Melanization in Cultured Melanocytes and within a 3-Dimensional Skin Equivalent Model.

Journal: The Journal of investigative dermatology

Published: January 19, 2024

Trends of Diagnosis, Disease Course, and Treatment of Atopic Dermatitis 2012-2021: Real-World Data from a Large Healthcare Provider.

Trends of Diagnosis, Disease Course, and Treatment of Atopic Dermatitis 2012-2021: Real-World Data from a Large Healthcare Provider.

Journal: Journal of clinical medicine

Published: November 22, 2023

Showing 1-12 of 18

Last Updated: 09/26/2026